Attached files
| file | filename |
|---|---|
| 10-K - 10-K - CALADRIUS BIOSCIENCES, INC. | clbs-10kx20171231.htm |
| EX-10.1 - EXHIBIT 10.1 - CALADRIUS BIOSCIENCES, INC. | exhibit101directorcompensa.htm |
| EX-23.1 - EXHIBIT 23.1 - CALADRIUS BIOSCIENCES, INC. | exh2312018.htm |
| EX-31.1 - EXHIBIT 31.1 - CALADRIUS BIOSCIENCES, INC. | clbs-ex311_20181231xq4.htm |
| EX-31.2 - EXHIBIT 31.2 - CALADRIUS BIOSCIENCES, INC. | clbs-ex312_20181231xq4.htm |
| EX-14.1 - EXHIBIT 14.1 - CALADRIUS BIOSCIENCES, INC. | exhibit141.htm |
| EX-21.1 - EXHIBIT 21.1 - CALADRIUS BIOSCIENCES, INC. | exh2112018.htm |
Exhibit 32
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Caladrius Biosciencs, Inc. a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2017 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: | March 22, 2018 | /s/ David J. Mazzo |
David J. Mazzo, PhD | ||
President and Chief Executive Officer | ||
(Principal Executive Officer) | ||
Dated: | March 22, 2018 | /s/ Joseph Talamo |
Joseph Talamo | ||
Senior Vice President and Chief Financial Officer | ||
(Principal Financial Officer) | ||